Skip to main content

Advertisement

SpringerLink
Log in

Clinical significance of endomyocardial biopsy in conjunction with cardiac magnetic resonance imaging to predict left ventricular reverse remodeling in idiopathic dilated cardiomyopathy

  • Original Article
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Abstract

Endomyocardial biopsy (EMB) and cardiac magnetic resonance (CMR) are useful modalities to study the characteristics of myocardial tissue. However, the prognostic impact of both diagnostic tools to predict subsequent left ventricular reverse remodeling (LVRR) has not been well elucidated. A total of 187 consecutive patients with idiopathic dilated cardiomyopathy (IDCM) who were treated by optimal pharmacotherapy (OPT) and underwent EMB of the LV wall were investigated. The myocardial specimens were semiquantitatively evaluated measuring cardiomyocyte degeneration (CD), interstitial fibrosis (IF), and hypertrophy. In addition, late gadolinium enhancement (LGE)-CMR was performed in 78 (48 %) patients. Seventy-eight (48 %) patients developed LVRR, defined as a ≥10 % increase in LV ejection fraction with a ≥10 % decrease in indexed LV end-diastolic dimension at 12 months after OPT. Multivariate regression analysis revealed that CD (P = 0.003), but not IF (P = 0.320), was an independent predictor of LVRR. In the patients with not only EMB but also CMR, the CD score and LGE area were independent predictors of LVRR (odds ratios/P values 0.268/0.010, 0.855/<0.001, respectively). The patients with mild CD and negative LGE had a better achievement rate of LVRR than those with severe CD and positive LGE (74 vs. 19 %). A combination of CD score on EMB and LGE-CMR is useful to predict subsequent LVRR in IDCM patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Hori M, Sasayama S, Kitabatake A, Toyo-oka T, Handa S, Yokoyama M, Matsuzaki M, Takeshita A, Origasa H, Matsui K, Hosoda S, Investigators MUCHA (2004) Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial. Am Heart J 147:324–330

    Article  CAS  PubMed  Google Scholar 

  2. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L, Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators (2005) The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Eng J Med 352:1539–1549

    Article  CAS  Google Scholar 

  3. Merlo M, Pyxaras SA, Pinamonti B, Barbati G, Di Lenarda A, Sinagra G (2011) Prevalence and prognostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatment. J Am Coll Cardiol 57:1468–1476

    Article  PubMed  Google Scholar 

  4. Choi JO, Kim EY, Lee GY, Lee SC, Park SW, Kim DK, Oh JK, Jeon ES (2013) Predictors of left ventricular reverse remodeling and subsequent outcome in nonischemic dilated cardiomyopathy. Circ J 77:462–469

    Article  PubMed  Google Scholar 

  5. JCS Joint Working Group (2013) Guidelines for treatment of acute heart failure (JCS 2011). Circ J 77:2157–2201

    Article  Google Scholar 

  6. Ikeda Y, Inomata T, Iida Y, Iwamoto-Ishida M, Nabeta T, Ishii S, Sato T, Yanagisawa T, Mizutani T, Naruke T, Koitabashi T, Takeuchi I, Nishii M, Ako J (2015) Time course of left ventricular reverse remodeling in response to pharmacotherapy: clinical implication for heart failure prognosis in patients with idiopathic dilated cardiomyopathy. Heart Vessels. doi:10.1007/s00380-015-0648-2

    PubMed Central  Google Scholar 

  7. Tsukada B, Terasaki F, Shimomura H, Otsuka K, Otsuka K, Katashima T, Fujita S, Imanaka-Yoshida K, Yoshida T, Hiroe M, Kitaura Y (2009) High prevalence of chronic myocarditis in dilated cardiomyopathy referred for left ventriculoplasty: expression of tenascin C as a possible marker for inflammation. Hum Pathol 40:1015–1022

    Article  CAS  PubMed  Google Scholar 

  8. Vasiljević JD, Otasević P, Popović ZB, Nesković AN, Vidaković R, Popović ZV, Radovancević B, Frazier OH, Gradinac S (2005) Semiquantitative histomorphometric analysis of myocardium following partial left ventriculectomy: 1-year follow-up. Eur J Heart Fail 7:763–767

    Article  PubMed  Google Scholar 

  9. Writing Committee Members, Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL, American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines (2013) 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 128:e240–e327

    Article  Google Scholar 

  10. Schwarz F, Mall G, Zebe H, Blickle J, Derks H, Manthey J, Kübler W (1983) Quantitative morphologic findings of the myocardium in idiopathic dilated cardiomyopathy. Am J Cardiol 51:501–506

    Article  CAS  PubMed  Google Scholar 

  11. Rose AG, Beck W (1985) Dilated (congestive) cardiomyopathy: a syndrome of severe cardiac dysfunction with remarkably few morphological features of myocardial damage. Histopathology 9:367–379

    Article  CAS  PubMed  Google Scholar 

  12. Shimura S, Matsui Y, Yutani C, Suto Y, Akashi O, Matsui K, Shingu Y, Sakakibara M, Yamaguchi M, Haruki Y, Takigami K, Minase T, Ueda T (2009) Histopathological study of specimens obtained by left ventricular biopsy during ventriculoplasty for idiopathic dilated cardiomyopathy. Tokai J Exp Clin Med 34:1–7

    PubMed  Google Scholar 

  13. Yamada T, Fukunami M, Ohmori M, Iwakura K, Kumagai K, Kondoh N, Kondoh N, Minamino T, Tsujimura E, Nagareda T, Kotoh K (1993) Which subgroup of patients with dilated cardiomyopathy would benefit from long-term beta-blocker therapy? A histologic viewpoint. J Am Coll Cardiol 21:628–633

    Article  CAS  PubMed  Google Scholar 

  14. Yamada Y, Saito S, Nishinaka T, Yamazaki K (2012) Myocardial size and fibrosis changes during left ventricular assist device support. ASAIO J 58:402–406

    Article  PubMed  Google Scholar 

  15. Kawai K, Takaoka H, Hata K, Yokoya Y, Yokoyama M (1999) Prevalence, predictors, and prognosis of reversal of maladaptive remodeling with intensive medical therapy in idiopathic dilated cardiomyopathy. Am J Cardiol 84:671–676

    Article  CAS  PubMed  Google Scholar 

  16. Bruckner BA, Stetson SJ, Perez-Verdia A, Youker KA, Radovancevic B, Connelly JH, Koerner MM, Entman ME, Frazier OH, Noon GP, Torre-Amione G (2001) Regression of fibrosis and hypertrophy in failing myocardium following mechanical circulatory support. J Heart Lung Transplant 20:457–464

    Article  CAS  PubMed  Google Scholar 

  17. Kubanek M, Sramko M, Maluskova J, Kautznerova D, Weichet J, Lupinek P, Vrbska J, Malek I, Kautzner J (2013) Novel predictors of left ventricular reverse remodeling in individuals with recent-onset dilated cardiomyopathy. J Am Coll Cardiol 61:54–63

    Article  PubMed  Google Scholar 

  18. Boehmer JP, Starling RC, Cooper LT, Torre-Amione G, Wittstein I, Dec GW, Markham DW, Zucker MJ, Gorcsan J 3rd, McTiernan C, Kip K, McNamara DM, Investigators IMAC (2012) Left ventricular assist device support and myocardial recovery in recent onset cardiomyopathy. J Card Fail 18:755–761

    Article  PubMed  Google Scholar 

  19. Delnoij T, van Suylen RJ, Cleutjens JP, Schalla S, Bekkers SC (2009) In vivo histology by cardiovascular magnetic resonance imaging. Eur Heart J 30:2492

    Article  PubMed  Google Scholar 

  20. Nabeta T, Inomata T, Iida Y, Ikeda Y, Iwamoto M, Ishii S, Sato T, Watanabe I, Naruke T, Shinagawa H, Koitabashi T, Takeuchi I, Nishii M, Inoue Y, Izumi T (2014) Baseline cardiac magnetic resonance imaging versus baseline endomyocardial biopsy for the prediction of left ventricular reverse remodeling and prognosis in response to therapy in patients with idiopathic dilated cardiomyopathy. Heart Vessels 29:784–792

    Article  PubMed  Google Scholar 

  21. Schalla S, Bekkers SC, Dennert R, van Suylen RJ, Waltenberger J, Crijns HJ, Heymans S (2010) Replacement and reactive myocardial fibrosis in idiopathic dilated cardiomyopathy: comparison of magnetic resonance imaging with right ventricular biopsy. Eur J Heart Fail 12:227–231

    Article  PubMed  Google Scholar 

  22. Wu KC, Weiss RG, Thiemann DR, Kitagawa K, Schmidt A, Dalal D, Lai S, Bluemke DA, Gerstenblith G, Marbán E, Tomaselli GF, Lima JA (2008) Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol 51:2414–2421

    Article  PubMed  PubMed Central  Google Scholar 

  23. Jellis C, Martin J, Narula J, Marwick TH (2010) Assessment of nonischemic myocardial fibrosis. J Am Coll Cardiol 56:89–97

    Article  CAS  PubMed  Google Scholar 

  24. Masci PG, Schuurman R, Andrea B, Ripoli A, Coceani M, Chiappino S, Todiere G, Srebot V, Passino C, Aquaro GD, Emdin M, Lombardi M (2013) Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study. Circ Cardiovasc Imaging 6:790–799

    Article  PubMed  Google Scholar 

  25. Suwa M, Otake Y, Moriguchi A, Ito T, Hirota Y, Kawamura K, Adachi I, Narabayashi I (1997) Iodine-123 metaiodobenzylguanidine myocardial scintigraphy for prediction of response to beta-blocker therapy in patients with dilated cardiomyopathy. Am Heart J 133:353–358

    Article  CAS  PubMed  Google Scholar 

  26. Noda S (1980) Histopathology of endomyocardial biopsies from patients with idiopathic cardiomyopathy; quantitative evaluation based on multivariate statistical analysis. Jpn Circ J 44:95–116

    Article  CAS  PubMed  Google Scholar 

  27. Dick MR, Unverferth DV, Baba N (1982) The pattern of myocardial degeneration in nonischemic congestive cardiomyopathy. Hum Pathol 13:740–744

    Article  CAS  PubMed  Google Scholar 

  28. Baroldi G (1988) Anatomy and quantification of myocardial cell death. Methods Achiev Exp Pathol 13:87–113

    CAS  PubMed  Google Scholar 

  29. Turillazzi E, Baroldi G, Silver MD, Parolini M, Pomara C, Fineschi V (2005) A systematic study of a myocardial lesion: colliquative myocytolysis. Int J Cardiol 104:152–157

    Article  CAS  PubMed  Google Scholar 

  30. Shimomura H, Terasaki F, Hayashi T, Kitaura Y, Isomura T, Suma H (2001) Autophagic degeneration as a possible mechanism of myocardial cell death in dilated cardiomyopathy. Jpn Circ J 65:965–968

    Article  CAS  PubMed  Google Scholar 

  31. Vigliano CA, Cabeza Meckert PM, Diez M, Favaloro LE, Cortés C, Fazzi L, Favaloro RR, Laguens RP (2011) Cardiomyocyte hypertrophy, oncosis, and autophagic vacuolization predict mortality in idiopathic dilated cardiomyopathy with advanced heart failure. J Am Coll Cardiol 57:1523–1531

    Article  PubMed  Google Scholar 

  32. Hoshikawa E, Matsumura Y, Kubo T, Okawa M, Yamasaki N, Kitaoka H, Furuno T, Takata J, Doi YL (2011) Effect of left ventricular reverse remodeling on long-term prognosis after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy. Am J Cardiol 107:1065–1070

    Article  CAS  PubMed  Google Scholar 

  33. Unverferth DV, Fetters JK, Unverferth BJ, Leier CV, Magorien RD, Arn AR, Baker PB (1983) Human myocardial histologic characteristics in congestive heart failure. Circulation 68:1194–1200

    Article  CAS  PubMed  Google Scholar 

  34. Roberts WC, Ferrans VJ (1975) Pathologic anatomy of the cardiomyopathies. Idiopathic dilated and hypertrophic types, infiltrative types, and endomyocardial disease with and without eosinophilia. Hum Pathol 6:287–342

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiovascular Medicine, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa, 252-0374, Japan

    Shunsuke Ishii, Takayuki Inomata, Teppei Fujita, Yuichiro Iida, Yuki Ikeda, Takeru Nabeta, Tomoyoshi Yanagisawa, Takashi Naruke, Tomohiro Mizutani, Toshimi Koitabashi, Ichiro Takeuchi & Junya Ako

Authors
  1. Shunsuke Ishii
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takayuki Inomata
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Teppei Fujita
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yuichiro Iida
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yuki Ikeda
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Takeru Nabeta
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Tomoyoshi Yanagisawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Takashi Naruke
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Tomohiro Mizutani
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Toshimi Koitabashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Ichiro Takeuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Junya Ako
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shunsuke Ishii.

Ethics declarations

Conflict of interest

The authors have nothing to disclose regarding this study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ishii, S., Inomata, T., Fujita, T. et al. Clinical significance of endomyocardial biopsy in conjunction with cardiac magnetic resonance imaging to predict left ventricular reverse remodeling in idiopathic dilated cardiomyopathy. Heart Vessels 31, 1960–1968 (2016). https://doi.org/10.1007/s00380-016-0815-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00380-016-0815-0

Keywords

Search

Navigation